Enzon Pharmaceuticals Inc (NASDAQ:ENZN)

Data as of Jan 23
 -0.01 / -1.01%
Today’s Change
Today|||52-Week Range

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Quarter 4
Quarter 1
Quarter 2
Quarter 3
Revenue and IncomeNet Revenues7.4M9.0M7.8M8.2M
Depreciation And Amortization14.0K0.000.00--
Operating ExpensesGross Income7.4M------
General Expenses1.4M508.0K836.0K571.0K
Research And Development190.0K0.00--0.00
Total Operating Expenses1.4M508.0K836.0K571.0K
Non-Operating ExpensesOperating Income6.0M8.5M6.9M7.6M
Extraordinary Charge-1.0M0.00----
Other Expenses792.0K109.0K-48.0K0.00
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income5.5M8.6M6.9M7.6M
Income Taxes0.00-55.0K0.00-1.0K
Net Income5.5M8.5M6.9M7.6M
Shares To Calculate EPSShares To Calculate EPS43.8M44.1M44.1M44.1M
Shares To Calculate EPS Diluted51.0M44.3M44.3M44.2M
Earnings Per ShareEPS$0.12$0.19$0.16$0.17
EPS Diluted$0.09$0.19$0.16$0.17

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.